Previous Article | Next Article ![]()
Infection and Immunity, June 2001, p. 3772-3781, Vol. 69, No. 6
Division of Immunology and Gnotobiology,
Institute of Microbiology, Czech Academy of Sciences,
Víde
Received 29 August 2000/Returned for modification 26 October
2000/Accepted 12 March 2001
Human endothelial as well as epithelial cells were shown to respond
to lipopolysaccharides (LPSs). However, the expression and release of
CD14 by these so-called CD14-negative cells have not been studied in
detail. We investigated three human intestinal epithelial cell lines
(ECLs), SW-480, HT-29, and Caco-2, for their expression of CD14 and
CD11c/CD18 as well as their responsiveness to endotoxins.
Fluorescence-activated cell sorter analysis revealed no expression of
CD11c/CD18, but there was low expression of membrane-bound CD14 on
HT-29, Caco-2, and SW-480 ECLs. Both Western blotting and reverse
transcription-PCR confirmed the CD14 positivity of all three intestinal
ECLs. No substantial modulation of CD14 expression was achieved after
6, 8, 18, 24, and 48 h of cultivation with 10-fold serial
dilutions of LPS ranging from 0.01 ng/ml to 100 µg/ml. Interestingly,
soluble CD14 was found in the tissue culture supernatants of all three
ECLs. Finally, only HT-29 and SW-480, and not Caco-2, cells responded
to LPS exposure (range, 0.01 ng/ml to 100 µg/ml) by interleukin 8 release. Thus, we show that HT-29, SW-480, and Caco-2 human intestinal
ECLs express membrane-bound CD14. As Caco-2 cells did not respond to
LPS, these cell lines might be an interesting model for studying the
receptor complex for LPS. The fact that human intestinal epithelial
cells are capable not only of expression but also of release of soluble
CD14 may have important implications in vivo, e.g., in shaping the
interaction between the mucosal immune system and bacteria in the gut
and/or in the pathogenesis of endotoxin shock.
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.6.3772-3781.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
CD14 Is Expressed and Released as Soluble CD14 by
Human Intestinal Epithelial Cells In Vitro: Lipopolysaccharide
Activation of Epithelial Cells Revisited
ková,1
ská 1083, 142 20 Prague 4, Czech
Republic,1 and Department of Pathology,
Nihon University School of Dentistry, 1-8-13 Kanda-Surugadai,
Chiyoda-ku, Tokyo 101, Japan2
*
Corresponding author. Mailing address: Autoimmunity and
Transplantation Division, The Walter and Eliza Hall Institute of
Medical Research, The Royal Melbourne Hospital PO, Parkville, 3050 Victoria, Australia. Phone: 61-3-93452563. Fax: 61-3-93470852. E-mail:
pdfunda{at}hotmail.com or funda{at}wehi.edu.au.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|